Pasadena, CANCT07753603Now EnrollingIRB Ready

Thyroid Eye Disease, TED Clinical Trial in Pasadena, CA

Access cutting-edge thyroid eye disease, ted treatment through this phase 3 clinical trial at a research site in Pasadena. Study-provided care at no cost to qualified participants.

Sponsored by Sling Therapeutics, Inc.

Quick Self-Assessment

See if you qualify for this Pasadena location

Preparing your pre-screening questions…

Expert Care in Pasadena

Access thyroid eye disease, ted specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related thyroid eye disease, ted treatment provided free

Apply for This Pasadena Location

Check if you qualify for this thyroid eye disease, ted clinical trial in Pasadena, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Pasadena

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Pasadena site if eligible
  4. 4Begin participation

About This Thyroid Eye Disease, TED Study in Pasadena

The goal of this clinical trial is to evaluate the efficacy, safety, and tolerability of linsitinib in participants with moderate to severe Thyroid Eye Disease (TED).

Sponsor: Sling Therapeutics, Inc.

Who Can Participate

Inclusion Criteria

Participants must be ≥ 18 years of age at Screening
Clinical diagnosis of Graves' Disease and/or autoimmune Hashimoto's thyroiditis associated with active moderate to severe TED with a CAS ≥ 3 (on the 7-item scale) for the most severely affected eye (primary study eye) at Screening and Baseline.
Moderate to severe active TED (not sight-threatening but has an appreciable impact on daily life), with diagnosis of TED within 15 months prior to the Screening visit and usually associated with 1 or more of the following: lid retraction ≥ 2 mm, moderate or severe soft tissue involvement, proptosis ≥ 3 mm above normal for race and gender, and/or inconstant or constant diplopia.
Participants must be euthyroid with the participant's baseline disease under control or have mild hypo- or hyperthyroidism (defined as free thyroxine \[FT4\] and free triiodothyronine levels \[FT3\] \< 50% above or below the normal limits of the central laboratory) at Screening.
Does not require immediate ophthalmic surgery, radiotherapy to orbits or other ophthalmological intervention at the time of Screening and is not planning for any such treatment during the course of the study.

Exclusion Criteria

Any progressing optic neuropathy due to TED that has worsened in the last 6 months in the opinion of the investigator.
Corneal decompensation unresponsive to medical management.
Previous orbital irradiation or orbital surgery in either eye.
Any glucocorticoid use (IV or oral) with a cumulative dose equivalent to ≥ 1 g of methylprednisolone or equivalent for the treatment of TED within 8 weeks of Screening.
Prior IGF-1R inhibitor therapy for any condition.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Pasadena?

Yes, this clinical trial (NCT07753603) has an active research site in Pasadena, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Thyroid Eye Disease, TED Treatment Options in Pasadena, CA

If you're searching for thyroid eye disease, ted treatment options in Pasadena, CA, this clinical trial (NCT07753603) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Pasadena research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced thyroid eye disease, ted specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all thyroid eye disease, ted clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Pasadena, CA

See all ankylosing spondylitis clinical trials recruiting in Pasadena — not just this study.

Browse Ankylosing Spondylitis Trials in Pasadena →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsErectile Dysfunction TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Pasadena?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Pasadena, CA